Clinicians discuss the rapidly evolving therapies, technology, and surgical approaches for early-stage NSCLC and take a fresh look at the future of care. Teamwork: A Multidisciplinary Approach to ...

Boehringer Ingelheim has a second positive trial under its belt for nerandomilast in pulmonary fibrosis, setting up regulatory filings. The new data from the 1,178-patient FIBRONEER-ILD study showed ...

The FDA has approved Boehringer Ingelheim's nerandomilast as a treatment for idiopathic pulmonary fibrosis (IPF), giving the company a successor to its blockbuster therapy Ofev. Phosphodiesterase (PDE ...

Using 21 st century diagnostics to overcome barriers for lung function testing in primary care: it is time to consider oscillometry Obstructive airways diseases, including asthma and COPD as the most ...

An office breathing test typically means you blow into a machine that measures how much air your lungs can take in and how quickly and forcefully you can blow it out. These numbers tell your doctor if ...